Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2014-02-03 | dimethyl fumarate | BiogenIdec (USA - MA) | multiple sclerosis |
Granting of a Market Authorisation in the EU |
2012-05-10 | rivaroxaban | Janssen Research & Development (J&J - USA) Bayer (Germany) | reduction of the risk of stent thrombosis in patients with Acute Coronary Syndrome (ACS) | Submission of an sNDA |
2016-09-27 | ConfirmMDx™ for Prostate Cancer | MDxHealth (Belgium) | prostate cancer |
Reimbursement |
2012-05-21 | natalizumab | BiogenIdec (USA) Elan (Ireland) | multiple sclerosis |
Submission of a Market Application in the EU |
2012-05-23 | ROR inhibitors | Kancera (Sweden) | leukemia and solid tumors |
|
2012-05-23 | eculizumab | Alexion Pharmaceuticals (USA - CT) | infection-associated haemolytic uraemic syndrome |
Granting of the orphan status in the EU |
2012-05-23 | Recombinant human interleukin-7 (CYT107) | Cytheris (France) | progressive multifocal leukoencephalopathy | |
2012-05-23 | talarozole | Stiefel Laboratories (GSK - UK) | autosomal recessive congenital ichtyosis |
Granting of the orphan status in the EU |
2012-05-23 | talarozole | Stiefel Laboratories (GSK - UK) | keratinopathic ichtyosis | |
2012-05-23 | talarozole | Stiefel Laboratories (GSK - UK) | recessive X-linked ichtyosis | |
2012-05-23 | 16-base single-stranded peptide nucleic acid oligonucleotide linked to a 7-amino acid peptide | Biogenera (Italy) | neuroblastoma |
Granting of a patent |
2012-05-23 | 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin (after administration of adeno-associated viral vector encoding an inducible short hairpin RNA targeting claudin-5) | Avena Therapeutics (Ireland) | retinitis pigmentosa |
Granting of the orphan status in the EU |
2012-05-23 | 2S, 4R ketoconazole | Cortendo (Sweden) | Cushing's syndrome |
Granting of the orphan status in the EU |
2012-05-23 | 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid | PTC Therapeutics (USA - NJ) | Becker muscular dystrophy |
Granting of the orphan status in the EU |
2012-05-23 | doxorubicin (administered after synthetic double-stranded siRNA oligonucleotide directed against claudin-5 complexed with polyethyleneimine) | Avena Therapeutics (Ireland) | glioma | |
2013-04-12 | givinostat | Italfarmaco (Italy) | Duchenne muscular distrophy |
Granting of the orphan status in the US |
2013-09-16 | human erythrocytes encapsulating inositol hexaphosphate | Erytech Pharma (France) | sickle cell disease | Granting of the orphan status in the EU |
2012-05-23 | ramucirumab | Eli Lilly (USA - IN) | hepatocellular carcinoma |
Granting of the orphan status in the EU |
2012-05-23 | recombinant adeno-associated viral vector containing human acid alfa-glucosidase-gene | TMC Pharma Services (UK) | glycogen storage disease type II or Pompe's disease | |
2012-05-23 | 1[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one | Nexus Oncology (UK) | chronic lymphocytic leukemia |
© 2024 Biopharmanalyses - Powered by Samacom+